As of 2026-04-02, the Relative Valuation of Revive Therapeutics Ltd (RVV.CN) is (0.34) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of Revive Therapeutics Ltd based on Relative Valuation is -1085.0%.
The range of the Relative Valuation is (0.28) - (0.41) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 23.5x | 19.6x |
| Forward P/E multiples | 15.2x - 22.8x | 19.0x |
| Fair Price | (0.28) - (0.41) | (0.34) |
| Upside | -899.2% - -1265.1% | -1085.0% |
| Date | P/E |
| 2026-03-27 | -1.96 |
| 2026-03-26 | -1.96 |
| 2026-03-25 | -1.96 |
| 2026-03-24 | -1.96 |
| 2026-03-23 | -2.24 |
| 2026-03-20 | -2.52 |
| 2026-03-19 | -2.80 |
| 2026-03-18 | -3.35 |
| 2026-03-17 | -3.91 |
| 2026-03-16 | -3.91 |
| 2026-03-13 | -3.35 |
| 2026-03-12 | -2.52 |
| 2026-03-11 | -2.24 |
| 2026-03-10 | -1.12 |
| 2026-03-09 | -1.12 |
| 2026-03-06 | -1.12 |
| 2026-03-05 | -1.12 |
| 2026-03-04 | -1.12 |
| 2026-03-03 | -1.12 |
| 2026-03-02 | -0.84 |
| 2026-02-27 | -0.56 |
| 2026-02-25 | -0.84 |
| 2026-02-24 | -0.84 |
| 2026-02-23 | -0.56 |
| 2026-02-20 | -0.84 |
| 2026-02-19 | -0.84 |
| 2026-02-18 | -0.56 |
| 2026-02-17 | -0.84 |
| 2026-02-13 | -0.56 |
| 2026-02-12 | -0.56 |
| 2026-02-10 | -0.56 |
| 2026-02-09 | -0.56 |
| 2026-02-06 | -0.56 |
| 2026-02-05 | -0.56 |
| 2026-02-04 | -0.56 |
| 2026-02-03 | -0.56 |
| 2026-02-02 | -0.56 |
| 2026-01-29 | -0.84 |
| 2026-01-28 | -0.56 |
| 2026-01-27 | -0.56 |
| 2026-01-26 | -0.56 |
| 2026-01-23 | -0.56 |
| 2026-01-22 | -0.56 |
| 2026-01-19 | -0.56 |
| 2026-01-16 | -0.56 |
| 2026-01-15 | -0.84 |
| 2026-01-14 | -0.84 |
| 2026-01-13 | -0.84 |
| 2026-01-12 | -0.84 |
| 2026-01-09 | -0.56 |